6 天前 - … during the first year of the COVID19 vaccination programme. They describe the
humoral (antibody) and cellular (T-… Rituximab treated patients were at increased risk of severe …

8 天前 - … -generation COVID-19 vaccines. Correspondingly, a ~20-fold lower potency to
neutralize … correlation between COVID-19 incidence decline and neutralizing antibody increase. …

10 天前 - … therapeutic options for treating COVID-19, plasma from patients who had recovered
from … COVID-19 treatment expanded, it became clear that the level of neutralizing antibody …

11 天前 - … The COVID-19 disease's severity may be influenced by the … utilised in medical
facilities to treat COVID-19. One of these … of human neutralizing antibodies block COVID-19 virus …

12 天前 - … question on the antiviral medications used for COVID-19. Overall, the manuscript
was … compared COVID-19 patients treated with antiviral medications to those not treated with …

14 天前 - … neutralizing antibodies (nAbs) have been issued for emergency use or tested for
treating … Strategies for designing innovative antibody drugs to combat the COVID-19 pandemic. …

14 天前 - … COVID-19 therapeutics treatment by setting and deprivation decile. This study
demonstrates differences in COVID-19 treatment-… and neutralising monoclonal antibodies for non-…

17 天前 - … that has been made in the treatment and prevention of COVID-19. Various vaccinations,
… Neutralizing and non-neutralizing antibodies are all associated with viral infections. …

19 天前 - … its effectiveness in curbing COVID-19 progression, especially … efficacy of NMabs
in treating COVID-19. This transient … of positive surrogate virus neutralizing antibodies (sVNT) …

21 天前 - … neutralized the SARS-CoV-2 variant of concern BA.5 both in vitro and in the hamster
model of COVID-19 … in use for the treatment of COVID-19 by intravenous administration; B5-…